Panacea Acquisition Corp.
Status: Deal Closed
U=S+W/3
W=S@11.5
IPO Proceeds, $M | $143.75M |
---|---|
IPO Date | Jul 1, 2020 |
CEO | Oleg Nodelman |
Left Lead | Cowen |
IPO Cash in Trust | 100.0% |
SPAC Tenor | 24 months |
IPO Sector |
Healthcare
Biotechnology |
IPO Geography | Global |
Target Company | Nuvation Bio |
Deal Announced | Oct 21, 2020 |
Deal Size, $M | $1,319.00M |
Deal Sector | Healthcare |
Deal Geography | US/Canada |
SEC Filings | www.sec.gov |
Approval Vote | Feb 9, 2021 |
Amendment Vote | TBD |
Closing Date | Feb 10, 2021 |
Formerly PANA
NUVB
NUVB/W
Price | $3.25 |
---|---|
Last closing price | $3.27 |
H/L, today | $3.19 / $3.43 |
H/L, 52-week | $0.95 / $2.55 |
Volume, today | 894,598 |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Price | $0.18 |
---|---|
Last closing price | $0.18 |
High/low price, today | $0.18 / $0.18 |
Volume, today | 310 |
Volume, 3-month avg. | N/A |
Price | |
---|---|
Volume, today | |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Panacea Acquisition Corp.:
- Structure and cap table
- 9 directors & officers
- 18 filings and events
- 1 underwriters
- 6 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Oleg Nodelman | 43 | CEO and Chairman |
Scott Perlen | 45 | CFO |
Scott Platshon | 28 | COO |
Caroline Stout | 29 | Secretary and Director |
Sarah Marriott | 43 | Director |
Daniel Bradbury | 59 | Director |
Graham Cooper | 50 | Director |
Faheem Hasnain | 62 | Director |
Shalini Sharp | 45 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Cowen | BR | 12,500,000 | units |
12,500,000 | units | ||
Up-Front UW fee | 2.00 | % | |
BCMA | 3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.
Filings
Sign in to view 18 filings.